Pictet Asset Management (UK)’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Pictet Asset Management (UK)’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$8.23M	Buy	+9,989	New	+$7.74M	0.01%	731

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

NIP

Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return

Pictet Asset Management (UK)'s OMIC Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2021: 9,989 shares worth $8.23M. The stake represents 0.01% of the portfolio and ranks #731 among its holdings.

52 funds tracked by Wall St. Rank hold OMIC as of Q2 2021.

Pictet Asset Management (UK) held 9,989 shares of Singular Genomics Systems, Inc. Common Stock worth $8.23M as of Q2 2021.
Singular Genomics Systems, Inc. Common Stock was a new Pictet Asset Management (UK) position in Q2 2021.
Singular Genomics Systems, Inc. Common Stock made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #731 holding.
52 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.